W
Wei Yu
Researcher at Zhejiang California International NanoSystems Institute
Publications - 7
Citations - 607
Wei Yu is an academic researcher from Zhejiang California International NanoSystems Institute. The author has contributed to research in topics: Gene & Cancer. The author has an hindex of 6, co-authored 7 publications receiving 549 citations. Previous affiliations of Wei Yu include Zhejiang University.
Papers
More filters
Journal ArticleDOI
Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach.
Dong Ding,Xiaoyan Lou,Dasong Hua,Wei Yu,Lisha Li,Jun Wang,Feng Gao,Na Zhao,Guoping Ren,Lanjuan Li,Biaoyang Lin,Biaoyang Lin +11 more
TL;DR: A massive anchored parallel sequencing method using next-generation sequencing to isolate and sequence HBV integrants and identified 8 genes that were recurrent target genes by HBV integration, suggesting a clonal expansion model in HCC development.
Journal ArticleDOI
The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis
Xuefeng Fang,Jae-Geun Yoon,Lisha Li,Wei Yu,Jiaofang Shao,Dasong Hua,Shu-Mei Zheng,Leroy Hood,David R. Goodlett,Gregory Foltz,Biaoyang Lin,Biaoyang Lin +11 more
TL;DR: It is shown that knockdown of the SOX2 gene in LN229 GBM cells reduces cell proliferation and colony formation, and thatSOX2 down regulates BEX1 and BEX2, two genes with tumor suppressor activity in GBM, potentially creating a bistable system in G BM cells.
Journal ArticleDOI
RNA-Seq Analyses Generate Comprehensive Transcriptomic Landscape and Reveal Complex Transcript Patterns in Hepatocellular Carcinoma
Qichao Huang,Biaoyang Lin,Biaoyang Lin,Hanqiang Liu,Xi Ma,Fan Mo,Wei Yu,Lisha Li,Hongwei Li,Tian Tian,Dong Wu,Feng Shen,Jinliang Xing,Zhi-Nan Chen +13 more
TL;DR: This study represents the most comprehensive characterization of HBV-related HCC transcriptome including exon level expression changes and novel splicing variants, which illustrated the power of RNA-seq and provided important clues for understanding the molecular mechanisms of HCC pathogenesis at system-wide levels.
Journal ArticleDOI
SOX2 Targets Fibronectin 1 to Promote Cell Migration and Invasion in Ovarian Cancer: New Molecular Leads for Therapeutic Intervention
Xiaoyan Lou,Xu Han,Chengmeng Jin,Wei Tian,Wei Yu,Dong Ding,Lihua Cheng,Bingding Huang,Huawei Jiang,Biaoyang Lin +9 more
TL;DR: It is suggested that the SOX2-FN1 axis is a key pathway in mediating the migration and invasion of ovarian cancer cells, and offers crucial molecular insights and promises to develop putative candidate therapeutic interventions in women with ovarian cancer.
Journal ArticleDOI
ChIP-seq and Functional Analysis of the SOX2 Gene in Colorectal Cancers.
Xuefeng Fang,Wei Yu,Lisha Li,Jiaofang Shao,Na Zhao,Qiyun Chen,Zhiyun Ye,Sheng-Cai Lin,Shu Zheng,Biaoyang Lin,Biaoyang Lin +10 more
TL;DR: An integrated expression profiling and ChIP-seq analysis show that SOX2 is involved in the BMP signaling pathway, steroid metabolic process, histone modifications, and many receptor-mediated signaling pathways such as IGF1R and ITPR2 (Inositol 1,4,5-triphosphate receptor, type 2).